KLRK1 and irritable bowel syndrome: Hammoudi et al. demonstrated that co-culturing IBD organoids with intestinal T-resident memory cells, along with inhibiting CD103 and NKG2D, can block lymphoepithelial interactions, thereby reducing cytotoxic immune responses and alleviating tissue damage associated with IBD symptoms [54].